Department of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Dis Colon Rectum. 2019 Jan;62(1):40-46. doi: 10.1097/DCR.0000000000001255.
Colorectal cancer invading the adjacent organs/structures is detected in 5% to 20% of all surgical interventions performed for the management of colorectal cancer.
Our purpose is to verify the safety and feasibility of laparoscopic surgery for the treatment of locally advanced colorectal cancer invading the adjacent organs.
This is a retrospective study.
The study was conducted at a single institution in Japan.
We compared the morbidity, appropriate oncological resection, and disease-free survival of laparoscopic and open multivisceral resection in patients with colorectal carcinoma in the period between 2007 and 2015.
The primary outcome measures were curative resection rate, morbidity rate, and recurrence of laparoscopic and open multivisceral resection in patients with colorectal cancer.
Thirty-one patients received laparoscopic surgery, and 50 received open surgery. The amount of blood loss was smaller in the laparoscopic group than in the open group (60 vs 595 mL, p < 0.01). Curative surgery was performed in 46 patients of the open group (92.0%) and in 30 patients of the laparoscopic group (96.8%). Days until oral intake (5 vs 7 days, p < 0.01) and postoperative hospital stay (14 vs 19 days, p < 0.01) were shorter in the laparoscopic group. Overall morbidity was not different between the groups (22.5% vs 40.0%). Three-year disease-free survival rates were 62.7% in the open group and 56.7% in the laparoscopic group (p = 0.5776).
This study was a retrospective small study conducted at a single institute.
Laparoscopic multivisceral resection may be a safe, less invasive alternative to open surgery, with less blood loss and shorter hospital stay, and was not inferior to open surgery based on long-term oncological end points. See Video Abstract at http://links.lww.com/DCR/A785.
在所有接受结直肠癌治疗的手术干预中,有 5%至 20%的患者发现大肠癌侵犯了邻近器官/结构。
我们旨在验证腹腔镜手术治疗侵犯邻近器官的局部晚期结直肠癌的安全性和可行性。
这是一项回顾性研究。
这项研究在日本的一家机构进行。
我们比较了 2007 年至 2015 年期间接受腹腔镜和开放式联合脏器切除术的结直肠癌患者的发病率、适当的肿瘤学切除和无病生存率。
主要观察指标是结直肠癌腹腔镜和开放式联合脏器切除术的根治性切除率、发病率和复发率。
31 例患者接受腹腔镜手术,50 例接受开放手术。腹腔镜组出血量明显少于开放组(60 比 595 毫升,p <0.01)。开放组有 46 例(92.0%)患者进行了根治性手术,腹腔镜组有 30 例(96.8%)患者进行了根治性手术。腹腔镜组患者的口服摄入天数(5 比 7 天,p <0.01)和术后住院天数(14 比 19 天,p <0.01)均较短。两组总发病率无差异(22.5%比 40.0%)。开放组和腹腔镜组的 3 年无病生存率分别为 62.7%和 56.7%(p=0.5776)。
本研究为单中心回顾性小样本研究。
腹腔镜联合脏器切除术可能是一种安全、微创的手术方法,出血量少,住院时间短,在长期肿瘤学终点方面并不逊于开放性手术。在 http://links.lww.com/DCR/A785 观看视频摘要。